VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹69 Cr | ₹60 Cr | ₹60 Cr | ₹62 Cr | ₹54 Cr |
What is the latest Operating Profit of VENUS REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹69 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹54 Cr |
How is Operating Profit of VENUS REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹69 Cr | 14.99 | |
| Mar2025 | ₹60 Cr | -0.71 | |
| Mar2024 | ₹60 Cr | -3.36 | |
| Mar2023 | ₹62 Cr | 15.50 | |
| Mar2022 | ₹54 Cr | - | |
Compare Operating Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,922.2 Cr | -1.4% | -11.8% | 227.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -1.4% |
-11.8% |
227.8% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses